Time to treatment benefit for adult patients with Fabry disease receiving agalsidase beta: data from the Fabry Registry - Ortiz A, Abiose A, Bichet DG, Cabrera G, Charrow J, Germain DP, Hopkin RJ, Jovanovic A, Linhart A, Maruti SS, Mauer M, Oliveira JP, Patel MR, Politei J, Waldek S, Wanner C, Yoo HW, Warnock DG (Journal Of Medical Genetics, 2016)